298. Hereditary pancreatitis Clinical trials / Disease details
Clinical trials : 95 / Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05664880 (ClinicalTrials.gov) | January 2023 | 7/12/2022 | A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis | A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis | Chronic Pancreatitis | Drug: Paricalcitol;Drug: Placebo | Cedars-Sinai Medical Center | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Not yet recruiting | 18 Years | 75 Years | All | 24 | Early Phase 1 | United States |